These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 38950114)
1. Response by Berry et al to Letter Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial". Berry C; Sidik NP; McEntegart MB; Circulation; 2024 Jul; 150(1):e5-e6. PubMed ID: 38950114 [No Abstract] [Full Text] [Related]
2. Letter by Nishi et al Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial". Nishi T; Saito Y; Kobayashi Y Circulation; 2024 Jul; 150(1):e3-e4. PubMed ID: 38950111 [No Abstract] [Full Text] [Related]
3. Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial. Sidik NP; Stanley B; Sykes R; Morrow AJ; Bradley CP; McDermott M; Ford TJ; Roditi G; Hargreaves A; Stobo D; Adams J; Byrne J; Mahrous A; Young R; Carrick D; McGeoch R; Corcoran D; Lang NN; Heggie R; Wu O; McEntegart MB; McConnachie A; Berry C Circulation; 2024 Jan; 149(1):7-23. PubMed ID: 37795617 [TBL] [Abstract][Full Text] [Related]
4. Letter by Sheikh et al Regarding Article, "Invasive Evaluation Of Patients With Angina in the Absence of Obstructive Coronary Artery Disease". Sheikh AR; Zeitz C; Beltrame JF Circulation; 2015 Nov; 132(20):e242. PubMed ID: 26572675 [No Abstract] [Full Text] [Related]
5. Letter by de Araújo Gonçalves et al Regarding Article, "Invasive Evaluation of Patients With Angina in the Absence of Obstructive Coronary Artery Disease". de Araújo Gonçalves P; Echavarria-Pinto M; Garcia-Garcia HM Circulation; 2015 Nov; 132(20):e241. PubMed ID: 26572674 [No Abstract] [Full Text] [Related]
6. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials. Mancini GBJ; Boden WE; Brooks MM; Vlachos H; Chaitman BR; Frye R; Bittner V; Hartigan PM; Dagenais GR Atherosclerosis; 2018 Oct; 277():186-194. PubMed ID: 29861270 [TBL] [Abstract][Full Text] [Related]
7. Angina pectoris: has the cornerstone of symptomatic coronary artery disease been moved? Hessian RC; Beanlands RS Can J Cardiol; 2007 Jun; 23(8):648-50. PubMed ID: 17593990 [No Abstract] [Full Text] [Related]
8. Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina: Analysis of the Irbesartan in Patients With Heart Failure and Preserved Systolic Function Trial. Badar AA; Perez-Moreno AC; Hawkins NM; Jhund PS; Brunton AP; Anand IS; McKelvie RS; Komajda M; Zile MR; Carson PE; Gardner RS; Petrie MC; McMurray JJ Circ Heart Fail; 2015 Jul; 8(4):717-24. PubMed ID: 26067854 [TBL] [Abstract][Full Text] [Related]
9. Angina pectoris 2023: With and without obstructive coronary artery disease: Epidemiology, diagnosis, prognosis, and treatment. Al-Lamee RK Vascul Pharmacol; 2024 Jun; 155():107285. PubMed ID: 38431201 [TBL] [Abstract][Full Text] [Related]
10. [Update coronary artery disease: important progresses in acute and chronic therapy]. Athanasiadis A; Sechtem U MMW Fortschr Med; 2012 Mar; 154(5):58-60. PubMed ID: 22624267 [No Abstract] [Full Text] [Related]
11. Relation of self-reported angina pectoris to inducible myocardial ischemia in patients with known coronary artery disease: the Heart and Soul Study. Gehi AK; Rumsfeld JS; Liu H; Schiller NB; Whooley MA Am J Cardiol; 2003 Sep; 92(6):705-7. PubMed ID: 12972112 [TBL] [Abstract][Full Text] [Related]
12. Mental Stress Testing in Women With Angina and No Obstructive Coronary Artery Disease. Ma H; Jiang W; Guo L; Yin H; Wang H; Liu Y; Bai B; Liu Q; Wang S; Geng Q J Am Coll Cardiol; 2023 Jun; 81(22):2210-2211. PubMed ID: 37257957 [No Abstract] [Full Text] [Related]
13. Health-related qualify of life, angina type and coronary artery disease in patients with stable chest pain. Rieckmann N; Neumann K; Feger S; Ibes P; Napp A; Preuß D; Dreger H; Feuchtner G; Plank F; Suchánek V; Veselka J; Engstrøm T; Kofoed KF; Schröder S; Zelesny T; Gutberlet M; Woinke M; Maurovich-Horvat P; Merkely B; Donnelly P; Ball P; Dodd JD; Hensey M; Loi B; Saba L; Francone M; Mancone M; Berzina M; Erglis A; Vaitiekiene A; Zajanckauskiene L; Harań T; Suckiel MI; Faria R; Gama-Ribeiro V; Benedek I; Rodean I; Adjić F; Čemerlić Adjić N; Rodriguez-Palomares J; Garcia Del Blanco B; Brooksbank K; Collison D; Davis G; Thwaite E; Knuuti J; Saraste A; Kępka C; Kruk M; Benedek T; Ratiu M; Neskovic AN; Vidakovic R; Diez I; Lecumberri I; Fisher M; Ruzsics B; Hollingworth W; Gutiérrez-Ibarluzea I; Dewey M; Müller-Nordhorn J Health Qual Life Outcomes; 2020 May; 18(1):140. PubMed ID: 32410687 [TBL] [Abstract][Full Text] [Related]
14. Effects of ranolazine in symptomatic patients with stable coronary artery disease. A systematic review and meta-analysis. Savarese G; Rosano G; D'Amore C; Musella F; Della Ratta GL; Pellegrino AM; Formisano T; Vitagliano A; Cirillo A; Cice G; Fimiani L; del Guercio L; Trimarco B; Perrone-Filardi P Int J Cardiol; 2013 Nov; 169(4):262-70. PubMed ID: 24063912 [TBL] [Abstract][Full Text] [Related]
15. Optimal Medical Therapy as First-Line Therapy for Chronic Coronary Syndromes: Lessons from COURAGE, BARI 2D, FAME 2, and ISCHEMIA. Brown DL Cardiovasc Drugs Ther; 2022 Oct; 36(5):1039-1045. PubMed ID: 34767134 [TBL] [Abstract][Full Text] [Related]